Hosted on 9 June 2026, OPT-MVAC’s third Regional Safety Group (ReSaG) webinar, facilitated by consortium partners from the Rabat Collaborating Center (RCC), focused on strengthening pharmacovigilance systems to support malaria vaccine rollout.
The objective of the session was to review findings from ReSaG Report 3, assess progress in malaria vaccine safety surveillance across OPT-MVAC countries, discuss challenges affecting reporting and investigation of adverse events, and identify priorities for strengthening pharmacovigilance systems at country level.
The session was recorded with simultaneous interpretation in English, French and Portuguese, and is available for viewing here (password: U+sT1kq5). Other downloadable resources include webinar meeting notes and the presentation slide deck.